Scheme 1. Development of the New Series of Isoxazole-Based Compounds.

P1/P3 binding isoxazole warhead was used as the starting core. Subsequent addition of a 4-phenyl linker and the dichlorophenol fragment generated the parent compound 5 providing higher potency and selectivity over human phosphatase PTP1B.